Ventricular arrhythmia burden and implantable cardioverter‐defibrillator outcomes in transthyretin cardiac amyloidosis

Background As targeted treatments for amyloid transthyretin cardiomyopathy (ATTR‐CM) are becoming available, we aim to characterize the rates of ventricular arrhythmias (VAs), implantable cardioverter‐defibrillator (ICD) utilization, and their impact on survival. Methods This is a retrospective coho...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Pacing and clinical electrophysiology 2022-04, Vol.45 (4), p.443-451
Hauptverfasser:	Brown, Matthew T., Yalamanchili, Sreeram, Evans, Sean T., Ram, Pradhum, Blank, Evan A., Lyle, Melissa A., Merchant, Faisal M., Bhatt, Kunal N.
Format:	Artikel
Sprache:	eng
Schlagworte:	Amyloid Amyloidosis Amyloidosis - diagnosis Arrhythmia Arrhythmias, Cardiac Cardiomyopathy Congestive heart failure Death, Sudden, Cardiac - prevention & control Defibrillators Defibrillators, Implantable Fibrillation Heart failure Heart rate Humans Implantable Cardioverter‐Defibrillator Prealbumin Retrospective Studies Sudden Cardiac Death Survival Tachycardia Tachycardia, Ventricular Transthyretin Ventricle Ventricular Arrhythmia
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!